← Human Trials & Peer-Reviewed Studies
Effect of high-fat meals and fatty acid saturation on postprandial levels of the hormones ghrelin and leptin in healthy men
Plain-language guide to PMID 16118648 (2006): double-blind randomized controlled trial study of Ghrelin.
Key Facts
- PMID
- 16118648
- Journal
- European journal of clinical nutrition
- Year
- 2006
- Study type
- Randomized Controlled Trial
- Authors
- Poppitt SD et al. (10 authors)
- DOI
- 10.1038/sj.ejcn.1602270
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial paper looks at Ghrelin.
The researchers investigated whether high-fat meals, which differed in saturated fatty acid (SFA) content acutely modified these hormones.
Who Took Part
By PubMed's age tags, the people studied were adults, men only.
Fasting and postprandial measurements of serum total ghrelin (RIA), leptin (enzyme-linked immunosorbent assay (ELISA)) and insulin (RIA) were made over 6 h.
Postprandial measurements were also made at 10 and 24 h following a fat-exclusion lunch, snack and dinner.
How the Study Was Run
The design is described as randomized, double-blind and crossover.
The participants were allocated by chance, so the Ghrelin group and the comparison group should start out alike.
Neither the participants nor the staff measuring them knew who was on Ghrelin, so expectations could not easily colour the readings.
In the crossover set-up each of the participants took both Ghrelin and the comparison in turn, acting as their own control.
Meals comprised either high (approximately 70:30) or low (approximately 55:45) saturated:unsaturated fatty acid (SFA:USFA) ratio.
A total of 18 lean, healthy men.
What Was Measured
The subject headings attached to it are Area Under Curve, Circadian Rhythm, Dietary Fats, Dietary Fats, Unsaturated, Fasting, Ghrelin and Insulin.
What This Means in Plain Language
The paper is a randomized, double-blind and crossover study of Ghrelin.
Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2006 (European journal of clinical nutrition), a journal based in England.
More context: the Ghrelin compound page, all human trials.
Our Notes on the Compound
Ghrelin: A 28-amino-acid stomach hormone that signals hunger and triggers growth hormone release; studied in human trials as an infusion.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.